Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia

Blood. 2001 Mar 15;97(6):1896. doi: 10.1182/blood.v97.6.1896.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Blood Cell Count
  • Bone Marrow / drug effects*
  • Bone Marrow / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / pharmacology
  • Interferon-alpha / toxicity
  • Male
  • Middle Aged
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / drug therapy*
  • Primary Myelofibrosis / pathology
  • Splenomegaly / drug therapy
  • Treatment Failure

Substances

  • Interferon-alpha